Podcast series
Let's talk OA
Podcast series about OA
Interviews with renowned OA experts
A podcast series brought to you by Laboratories Expanscience, where together with our host, Dr. Simon Fleming, an Orthopaedic Doctor & Change Maker, we invite you to tune into interviews and talks with key world renowned experts to discuss ‘all things Osteoarthritis’. This podcast series is available on Spotify and Apple Podcasts. This podcast series is available on Spotify and Apple Podcasts.
Access on your favorite platforms:
Interviews with renowned OA experts
A podcast series brought to you by Laboratories Expanscience, where together with our host, Dr. Simon Fleming, an Orthopaedic Doctor & Change Maker, we invite you to tune into interviews and talks with key world renowned experts to discuss ‘all things Osteoarthritis’. This podcast series is available on Spotify and Apple Podcasts. This podcast series is available on Spotify and Apple Podcasts.
Tune into your favorite platform:
Or listen to the episodes directly on OASIS:
Episode 1
An international and cross-functional approach to Osteoarthritis
Prof. Yves Henrotin, Professor at the University of Liège (Belgium), Head of the Physical Therapy & Rehabilitation Department at the Princesse Paola Hospital (Belgium).
In this episode, Prof. Yves Henrontin, a world renowned expert in the OA field shares his opinion on key aspects around this disease, such as the increase in incidence, prevalence, rising risk factors and comorbidities that OA patients are facing. This is a general update in OA you won’t want to miss.
Episode 2
Daily life of patients with OA: mechanical impact
Dr. Gustavo Constantino de Campos, PHD PHD in Trauma Orthopedics and Member of the Orthopedics and Traumatology Dept. at the University of Campinas (Brazil).
Dr. Gustavo Constantino de Campos and our host Dr. Simon Fleming help us to understand, step-by-step, the implications and mechanical impact of OA on patient’s lives and how this pathology can affect even the simplest activities due to disability or restricted mobility caused by pain.
Episode 3
Beyond the Body: psychological and social impact of OA
Mrs. Céline Mathy, Clinical psychologist and Guidance counsellor at the University of Liège (Belgium).
Mrs. Céline Mathy will make a deep dive into the different coping mechanisms for those living with OA, from a psychological perspective. She will guide us through the identification of signs related to depression in OA patients, as well as how we can take actions early to benefit patient’s quality of life.
Episode 4
Testimony: A day in the life of an OA patient
In this episode, you will have the chance to listen exclusively from a patient about how osteoarthritis has affected her life.
This is Monique, 80 years old, who has lived with osteoarthritis for most of her life, and who has agreed to share her journey with the medical community. She will talk about how she has seen her osteoarthritis progress and the impact of this disease on her mobility and daily activities. This is a reminder to us, as healthcare professionals, of the importance of the patient journey and our responsibility to continue to explore opportunities to find ways to improve the quality of life of patients.
Episode 5
OA as a serious disease: OARSI & FDA agree
Prof. Ali Mobasheri, President of the Osteoarthritis Research Society International, OARSI.
What is a serious disease and why is Osteoarthritis a serious disease? Prof. Ali Mobasheri, walks us through the OARSI White Paper submission, the key and future steps to find ways to make this serious disease that is chronic feel more acute. But, why was OA not considered a serious disease before? What impact does this new classification have in the way we treat patients? This and more in this episode!
Episode 6
EULAR & OARSI Congresses in 2021: Highlights
Dr. Anthony Criquet, Former Global Medical Affairs Director at Laboratoires Expanscience
Episode 7
The correct Diagnosis of OA: the first and key step
Dr. Luis Vidal, Director of the Rheumatology Department at María Auxiliadora Hospital (Peru) and Medical Director of CEDOR
Episode 8
OA diagnosis: WOMAC & LEQUESNE algofunctional indexes
Prof. Fadoua Allali, Director of the Rheumatology Department at the El Ayachi Hospital.
Episode 9
Nutrition and obesity in OA: False myths and advice
Prof. Fadoua Allali, Director of the Rheumatology Department at the El Ayachi Hospital.
Episode 10
Physical Exercise and OA
Prof. Kim Bennell, Professor Redmond Barry NHMRC Research Fellow in the Department of Physiotherapy at the University of Melbourne.
Episode 11
Patient adherence to OA Treatment
Patient adherence to pharmacological and non-pharmacological treatment is something physicians often struggle with, and OA is no exception. Listen to this podcast with Dr. Chalem and Pilar, an osteoarthritis patient, to understand why OA patients do or do not follow recommended treatments. Together they will help us gather some key takeaways to better understand and support our OA patients within the clinic, but also beyond its walls. Thank you, Pilar & Monique, for this wonderful discussion.
Episode 12
The two sides of NSAIDs
Dr. Pascal Hilliquin, Dr. Pascal Hilliquin Head of Rheumatology Department, South Francilien Hospital Centre
Dr. Pascal Hilliquin, who is Head of the Rheumatology Department at the Central Hospital of Southern Paris in Corbeil-Essonnes in France, is joining “Let’s Talk OA” to talk about how NSAIDs recommendations change in the short, mid and long term scenarios as well as in the earlier stages of OA. Although each patient should always be analysed individually, there are many general aspects you won’t want to miss. Dr. Hilliquin will be joining us on another episode so stay tuned for more.
Episode 13
SYSADOAs a slow but steady option to manage Knee OA
Prof. Yves Henrotin, Professor at the University of Liège (Belgium)
NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) can raise several concerns when their long-term intake is maintained, so listen below to some valuable data and clinical experience to gain the perspective of another expert regarding medium and long-term treatment.
Episode 14 Part 1
Decision making: is it time for surgery?
Dr. Andrés Silberman,Traumatologist – Orthopaedic Physician
Dr. Juan Carlos Cajigas, Rheumatologist
Drs. Andrés Silberman and Juan Carlos Cajigas join “Let’s Talk OA” to discuss the optimal timing for operating on patients with OA, along with Dr. Simon Fleming, our host for this podcast series.
Episode 14 Part 2
Decision making: is it time for surgery?
Dr. Andrés Silberman,Traumatologist – Orthopaedic Physician
Dr. Juan Carlos Cajigas, Rheumatologist
Some surgeons choose early surgery, while others prefer to exhaust all treatment options in a hierarchical order. The conclusion is clear: adopting a patient-centered approach that can be tailored to their lifestyle, needs, and pain levels. All crucial aspects for this decision-making process.
Episode 15
Post-OP: treatment, follow-up and recommendations
Dr. Noel Carilo, Orthopedic Surgeon specialized in Orthopedic Traumatology of the hand and microsurgery.
Dr. Simon Fleming and orthopedic surgeon Dr. Noel Carilo, discuss the post-surgical action process in patients with osteoarthritis. They cover topics such as the type of patients likely to be operated on, the various possible interventions, the treatments to be followed postoperatively or the assistance to be provided to patients in the recovery process.
Episode 16
Patient Associations as support systems and sheir role in OA
Prof. Yves Henrotin, Professor at the University of Liège (Belgium)
Prof. Yves Henrotin is back to help us understand the role of Patient Associations and Societies in innovation and support for patients with osteoarthritis. In previous podcasts we have already talked about the different types of treatment for this pathology. In this episode, we will discover the essential role of patient associations in decision-making, particularly at the international level.
Episode 17
Early OA
Dr. Demirhan Dıraçoğlu, Professor of the Faculty of Medicine, Faculty of Physical Medicine and Rehabilitation, Istanbul University
Early detection of OA is essential to prevent progression into the most advanced stages of the disease. Dr. Demirhan Dıraçoğlu, Professor at the Faculty of Medicine in the University of Istanbul and member of various groups focused on osteoarthritis, joins “Let’s Talk OA” to tell us why early OA is key for patients’ outcomes in terms of quality of life.
Episode 18
How to increase awareness of OA?
Mrs. Françoise Alliot-Launois, President of AFLAR (Association Française Contre le Rheumatisme)
One of the greatest challenges in the lives of patients with osteoarthritis is undoubtedly that they suffer from a disease invisible to the naked eye. Several international associations and foundations take the awareness of osteoarthritis very seriously and make it one of their main missions. In this episode, Mrs. Françoise Alliot will share some of the initiatives and activities carried out internationally with other associations, healthcare professionals, public entities, and other stakeholders in the field of osteoarthritis.
Episode 19
How unconventional approaches could help OA patients?
Prof. Gregory Ninot, PhD in Sports Science and Psychology, Associate Director, Desbrest Institute of Epidemiology and Public Health
Professor Gregory Ninot will share a different approach to osteoarthritis by explaining how non-conventional or non-pharmacological interventions can help patients with osteoarthritis.
Episode 20
What you missed from EULAR 2022
Dr. Ivone Karina Ruiz López, Medical Director of the General Hospital of Mexico “Dr. Eduardo Liceaga”.
Two years after the COVID-19 pandemic, the EULAR (European Alliance of Associations for Rheumatology) congress returned to a face-to-face format this summer 2022. To tell us about it, we welcome rheumatologist Dr. Ivone Karina Ruiz Lopez. In this episode, she will share the main highlights from the congress as a personal review of the sessions she attended. Dr. Ruiz is Vice Principal Medical Director at the General Hospital of Mexico “Dr. Eduardo Liceaga” and Executive Secretary of the Mexican College of Rheumatology AC.
Episode 21
Summary from the Stop Arthrose Survey
Mrs. Céline Mathy, Clinical Psychologist and General Director of the Arthrose Foundation
Mrs. Céline Mathy joins us today to present the results of the Stop Arthrose 2019-2021 patient study. This study, conducted in Belgium and France, showcases the progression of osteoarthritis from the perspective of the patients. This, in contrast to the previous wave and Mrs. Mathy’s clinical experience as a psychologist, may lead us to a better understanding of why significant advances in osteoarthritis seem to be… stalled.
Episode 22
Adherence: the key factor in osteoarthritis
Dr. Andres Silberman, Professor of Orthopedics and Tramulatology, School of Medicine, University of Buenos Aires
Dr Andrés Silberman explains the importance of adherence in osteoarthritis by looking at the evolution of adherent and non-adherent patients. He will also explain the different ways of measuring adherence in osteoarthritis and what actions can be done to help patients become more adherent.
Episode 23
OA and Genetics: Is there a verdict?
Dr. Yusuf Erdem, Orthopedic surgeon at the Gulhane Information and Research Hospital.
To date, is little known about the genetic backgroun of OA. Today we have the opportunity to listen to our guest, Dr. Yusuf Erdem, Orthopaedic surgeon in Gulhane Training and Research Hospital. He will share with us if there is any scientific evidence that associates genes with risks of developing OA, understand what is the rol of genetics behind this disease.
Episode 24 Part 1
The invisible ways OA speaks up
Dra. Ivette Calderón, Rheumatologist and President of the Social Networking Committee of the Mexican College of Rheumatolog
OA is a progressive disease that is why early detection is so important as early identification can have a major impact on a patient’s well-being. In this episode, Dra. Calderón will emphasize on the social and economic impact of early OA detection and in the patient’s role in early diagnosis.
Episode 24 Part 2
The invisible ways OA speaks up
Dra. Ivette Calderón, Rheumatologist and President of the Social Networking Committee of the Mexican College of Rheumatolog
OA is a progressive disease that is why early detection is so important as early identification can have a major impact on a patient’s well-being. In this episode, Dra. Calderón will emphasize on the social and economic impact of early OA detection and in the patient’s role in early diagnosis.
Episode 25 Part 1
Comorbidities after OA diagnosis
Dr. Francisco Airton, MD, PhD; Professor of Rheumatology at the Faculty of Medicine of the Federal University of Ceará, Brasil.
